Bertsllc
1 year ago
Hepion Pharmaceuticals to Participate in ACS-JPS Webinar on AI Drug Development
EDISON, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (βAIβ)-driven therapeutic drug development for the treatment of fibrotic diseases, including non-alcoholic steatohepatitis (βNASHβ), hepatocellular carcinoma (βHCCβ), and other chronic diseases, announces that its Chief Executive Officer, Robert Foster, PharmD, PhD, and its Senior Vice President for Clinical Pharmacology and Analytics, Patrick Mayo, PhD, will be presenting during a webinar entitled βHow Artificial Intelligence is Changing Drug Discoveryβ on Thursday, March 23rd at 1:00 p.m. Eastern Time.
https://finance.yahoo.com/news/hepion-pharmaceuticals-participate-acs-jps-201000894.html